ClinicalTrials.gov
public full text
Public Domain
Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease
The primary objective of the study is to assess the dose response and the dose frequency of epratuzumab in patients with SLE.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors#966329
- Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse#1058913
- A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus#1464734
- A Phase 1 Study of AV-380 in Healthy Subjects#825648
- A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC#887617
Record · ID 1477462
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive